# A Pharmacokinetic Study of JS002 in Healthy Subjects

> **NCT05859529** · PHASE1 · COMPLETED · sponsor: **Shanghai Junshi Bioscience Co., Ltd.** · enrollment: 318 (actual)

## Conditions studied

- Health Volunteer

## Interventions

- **DRUG:** JS002

## Key facts

- **NCT ID:** NCT05859529
- **Lead sponsor:** Shanghai Junshi Bioscience Co., Ltd.
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-05-30
- **Primary completion:** 2023-06-30
- **Final completion:** 2023-09-11
- **Target enrollment:** 318 (ACTUAL)
- **Last updated:** 2024-09-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05859529

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05859529, "A Pharmacokinetic Study of JS002 in Healthy Subjects". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05859529. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*